1
|
Haefner J, Navarro KE, Guenette R, Jones BJP, Tripathi A, Adams C, Almazán H, Álvarez V, Aparicio B, Aranburu AI, Arazi L, Arnquist IJ, Auria-Luna F, Ayet S, Azevedo CDR, Bailey K, Ballester F, Barrio-Torregrosa MD, Bayo A, Benlloch-Rodríguez JM, Borges FIGM, Brodolin A, Byrnes N, Cárcel S, Carrión JV, Cebrián S, Church E, Cid L, Conde CAN, Contreras T, Cossío FP, Dey E, Díaz G, Dickel T, Elorza M, Escada J, Esteve R, Felkai R, Fernandes LMP, Ferrario P, Ferreira AL, Foss FW, Freitas EDC, Freixa Z, Generowicz J, Goldschmidt A, Gómez-Cadenas JJ, González R, Grocott J, Hafidi K, Hauptman J, Henriques CAO, Morata JAH, Herrero-Gómez P, Herrero V, Hervés Carrete C, Ifergan Y, Labarga L, Larizgoitia L, Larumbe A, Lebrun P, Lopez F, López-March N, Madigan R, Mano RDP, Marques AP, Martín-Albo J, Martínez-Lema G, Martínez-Vara M, Meziani ZE, Miller RL, Mistry K, Molina-Canteras J, Monrabal F, Monteiro CMB, Mora FJ, Muñoz Vidal J, Novella P, Nuñez A, Nygren DR, Oblak E, Palacio J, Palmeiro B, Para A, Parmaksiz I, Pelegrin J, Pérez Maneiro M, Querol M, Redwine AB, Renner J, Rivilla I, Rodríguez J, Rogero C, Rogers L, Romeo B, Romo-Luque C, Santos FP, dos Santos JMF, Shomroni I, Simón A, Soleti SR, Sorel M, Soto-Oton J, Teixeira JMR, Toledo JF, Torrent J, Trettin A, Usón A, Veloso JFCA, Waiton J, White JT. Demonstration of event position reconstruction based on diffusion in the NEXT-white detector. Eur Phys J C Part Fields 2024; 84:518. [PMID: 38784120 PMCID: PMC11108901 DOI: 10.1140/epjc/s10052-024-12865-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Accepted: 04/29/2024] [Indexed: 05/25/2024]
Abstract
Noble element time projection chambers are a leading technology for rare event detection in physics, such as for dark matter and neutrinoless double beta decay searches. Time projection chambers typically assign event position in the drift direction using the relative timing of prompt scintillation and delayed charge collection signals, allowing for reconstruction of an absolute position in the drift direction. In this paper, alternate methods for assigning event drift distance via quantification of electron diffusion in a pure high pressure xenon gas time projection chamber are explored. Data from the NEXT-White detector demonstrate the ability to achieve good position assignment accuracy for both high- and low-energy events. Using point-like energy deposits from 83mKr calibration electron captures (E ∼ 45 keV), the position of origin of low-energy events is determined to 2 cm precision with bias < 1 mm. A convolutional neural network approach is then used to quantify diffusion for longer tracks (E ≥ 1.5 MeV), from radiogenic electrons, yielding a precision of 3 cm on the event barycenter. The precision achieved with these methods indicates the feasibility energy calibrations of better than 1% FWHM at Qββ in pure xenon, as well as the potential for event fiducialization in large future detectors using an alternate method that does not rely on primary scintillation.
Collapse
Affiliation(s)
- J. Haefner
- Department of Physics, Harvard University, Cambridge, 02138 MA USA
| | - K. E. Navarro
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - R. Guenette
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - B. J. P. Jones
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - A. Tripathi
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - C. Adams
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - H. Almazán
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - V. Álvarez
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - B. Aparicio
- Department of Organic Chemistry I, University of the Basque Country (UPV/EHU), Centro de Innovación en Química Avanzada (ORFEO-CINQA), 20018 San Sebastián/Donostia, Spain
| | - A. I. Aranburu
- Department of Applied Chemistry, Universidad del Pais Vasco (UPV/EHU), Manuel de Lardizabal 3, 20018 San Sebastián/Donostia, Spain
| | - L. Arazi
- Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, 8410501 Israel
| | - I. J. Arnquist
- Pacific Northwest National Laboratory (PNNL), Richland, WA 99352 USA
| | - F. Auria-Luna
- Department of Organic Chemistry I, University of the Basque Country (UPV/EHU), Centro de Innovación en Química Avanzada (ORFEO-CINQA), 20018 San Sebastián/Donostia, Spain
| | - S. Ayet
- II. Physikalisches Institut, Justus-Liebig-Universitat Giessen, Giessen, Germany
| | - C. D. R. Azevedo
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - K. Bailey
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - F. Ballester
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - M. del Barrio-Torregrosa
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - A. Bayo
- Laboratorio Subterráneo de Canfranc, Paseo de los Ayerbe s/n, Canfranc Estación, 22880 Spain
| | - J. M. Benlloch-Rodríguez
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - F. I. G. M. Borges
- LIP, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - A. Brodolin
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Centro de Física de Materiales (CFM), CSIC and Universidad del Pais Vasco (UPV/EHU), Manuel de Lardizabal 5, 20018 San Sebastián/Donostia, Spain
| | - N. Byrnes
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - S. Cárcel
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - J. V. Carrión
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - S. Cebrián
- Centro de Astropartículas y Física de Altas Energías (CAPA), Universidad de Zaragoza, Calle Pedro Cerbuna, 12, 50009 Zaragoza, Spain
| | - E. Church
- Pacific Northwest National Laboratory (PNNL), Richland, WA 99352 USA
| | - L. Cid
- Laboratorio Subterráneo de Canfranc, Paseo de los Ayerbe s/n, Canfranc Estación, 22880 Spain
| | - C. A. N. Conde
- LIP, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - T. Contreras
- Department of Physics, Harvard University, Cambridge, 02138 MA USA
| | - F. P. Cossío
- Department of Applied Chemistry, Universidad del Pais Vasco (UPV/EHU), Manuel de Lardizabal 3, 20018 San Sebastián/Donostia, Spain
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - E. Dey
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - G. Díaz
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - T. Dickel
- II. Physikalisches Institut, Justus-Liebig-Universitat Giessen, Giessen, Germany
| | - M. Elorza
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - J. Escada
- LIP, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - R. Esteve
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - R. Felkai
- Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, 8410501 Israel
- Present Address: Weizmann Institute of Science, Rehovot, Israel
| | - L. M. P. Fernandes
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - P. Ferrario
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Ikerbasque (Basque Foundation for Science), 48009 Bilbao, Spain
| | - A. L. Ferreira
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - F. W. Foss
- Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019 USA
| | - E. D. C. Freitas
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - Z. Freixa
- Department of Applied Chemistry, Universidad del Pais Vasco (UPV/EHU), Manuel de Lardizabal 3, 20018 San Sebastián/Donostia, Spain
- Ikerbasque (Basque Foundation for Science), 48009 Bilbao, Spain
| | - J. Generowicz
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - A. Goldschmidt
- Lawrence Berkeley National Laboratory (LBNL), 1 Cyclotron Road, Berkeley, CA 94720 USA
| | - J. J. Gómez-Cadenas
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Ikerbasque (Basque Foundation for Science), 48009 Bilbao, Spain
| | - R. González
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - J. Grocott
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - K. Hafidi
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - J. Hauptman
- Department of Physics and Astronomy, Iowa State University, Ames, IA 50011-3160 USA
| | - C. A. O. Henriques
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - J. A. Hernando Morata
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - P. Herrero-Gómez
- Hebrew University, Edmond J. Safra Campus, Jerusalem, 9190401 Israel
| | - V. Herrero
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - C. Hervés Carrete
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - Y. Ifergan
- Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, 8410501 Israel
| | - L. Labarga
- Departamento de Física Teórica, Universidad Autónoma de Madrid, Campus de Cantoblanco, 28049 Madrid, Spain
| | - L. Larizgoitia
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - A. Larumbe
- Department of Organic Chemistry I, University of the Basque Country (UPV/EHU), Centro de Innovación en Química Avanzada (ORFEO-CINQA), 20018 San Sebastián/Donostia, Spain
| | - P. Lebrun
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Lopez
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - N. López-March
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - R. Madigan
- Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. D. P. Mano
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A. P. Marques
- LIP, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - J. Martín-Albo
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - G. Martínez-Lema
- Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, 8410501 Israel
| | - M. Martínez-Vara
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | | | - R. L. Miller
- Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019 USA
| | - K. Mistry
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - J. Molina-Canteras
- Department of Organic Chemistry I, University of the Basque Country (UPV/EHU), Centro de Innovación en Química Avanzada (ORFEO-CINQA), 20018 San Sebastián/Donostia, Spain
| | - F. Monrabal
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Ikerbasque (Basque Foundation for Science), 48009 Bilbao, Spain
| | - C. M. B. Monteiro
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - F. J. Mora
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - J. Muñoz Vidal
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - P. Novella
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - A. Nuñez
- Laboratorio Subterráneo de Canfranc, Paseo de los Ayerbe s/n, Canfranc Estación, 22880 Spain
| | - D. R. Nygren
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - E. Oblak
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - J. Palacio
- Laboratorio Subterráneo de Canfranc, Paseo de los Ayerbe s/n, Canfranc Estación, 22880 Spain
| | - B. Palmeiro
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - A. Para
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - I. Parmaksiz
- Department of Physics, University of Texas at Arlington, Arlington, 76019 TX USA
| | - J. Pelegrin
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - M. Pérez Maneiro
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - M. Querol
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - A. B. Redwine
- Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva, 8410501 Israel
| | - J. Renner
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - I. Rivilla
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Ikerbasque (Basque Foundation for Science), 48009 Bilbao, Spain
| | - J. Rodríguez
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - C. Rogero
- Centro de Física de Materiales (CFM), CSIC and Universidad del Pais Vasco (UPV/EHU), Manuel de Lardizabal 5, 20018 San Sebastián/Donostia, Spain
| | - L. Rogers
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - B. Romeo
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - C. Romo-Luque
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - F. P. Santos
- LIP, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - J. M. F. dos Santos
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - I. Shomroni
- Hebrew University, Edmond J. Safra Campus, Jerusalem, 9190401 Israel
| | - A. Simón
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - S. R. Soleti
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
| | - M. Sorel
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - J. Soto-Oton
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - J. M. R. Teixeira
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - J. F. Toledo
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - J. Torrent
- Donostia International Physics Center, BERC Basque Excellence Research Centre, Manuel de Lardizabal 4, 20018 San Sebastián/Donostia, Spain
- Escola Politècnica Superior, Universitat de Girona, Av. Montilivi, s/n, 17071 Girona, Spain
| | - A. Trettin
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - A. Usón
- Instituto de Física Corpuscular (IFIC), CSIC and Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Spain
| | - J. F. C. A. Veloso
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - J. Waiton
- Department of Physics and Astronomy, Manchester University, Manchester, M13 9PL UK
| | - J. T. White
- Department of Physics and Astronomy, Texas A &M University, College Station, TX 77843-4242 USA
| |
Collapse
|
2
|
Athey JM, Vieson MD, Bailey K, Rudmann D, Baumgartner WA, Selting KA. Canine thyroid carcinomas: A review with emphasis on comparing the compact subtype of follicular thyroid carcinomas and medullary thyroid carcinomas. Vet Pathol 2024; 61:7-19. [PMID: 37306003 DOI: 10.1177/03009858231177225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Canine thyroid carcinomas are relatively common malignant endocrine neoplasms in dogs derived from either thyroid follicular cells (forming follicular thyroid carcinomas) or medullary cells (parafollicular, C-cells; forming medullary thyroid carcinomas). Older and recent clinical studies often fail to discriminate between compact cellular (solid) follicular thyroid carcinomas and medullary thyroid carcinomas, which may skew conclusions. The compact subtype of follicular thyroid carcinomas appears to be the least differentiated subtype of follicular thyroid carcinomas and needs to be differentiated from medullary thyroid carcinomas. This review includes information on the signalment, presentation, etiopathogenesis, classification, histologic and immunohistochemical diagnosis, clinical management, and biochemical and genetic derangements of canine follicular and medullary carcinomas, and their correlates with human medicine.
Collapse
|
3
|
White K, Rolock N, Hambrick E, Bai R, Bender A, Evans K, Diamant-Wilson R, Bailey K. Longitudinal Evaluation of the Neurosequential Model of Therapeutics with Adoptive Families in Tennessee. J Evid Based Soc Work (2019) 2023; 20:1004-1025. [PMID: 37573514 DOI: 10.1080/26408066.2023.2245819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/15/2023]
Abstract
PURPOSE This study evaluated effectiveness of the Neurosequential Model of Therapeutics (NMT) with adoptive families who received post adoption services in Tennessee. METHODS Researchers obtained a sample of 552 families who received post adoption services in the U.S. state of Tennessee. Most families (77%) had adopted children through public child welfare services. A quasi-experimental design examined wellbeing outcomes for an NMT group (n = 319) versus a services-as-usual (SAU) group (n = 233) in intent-to-treat analyses. Then, the SAU group was contrasted to an NMT subgroup that had high adherence to the NMT model (n = 109) in an analysis of treatment-on-the-treated. RESULTS Intent-to-treat models indicated no differences on outcomes between the NMT and SAU groups. However, the results of treatment-on-the-treated analyses showed slightly greater reduction on the Behavior Problems Index over time for the NMT with high adherence group as compared to SAU. DISCUSSION AND CONCLUSION Adoptive families may face challenges that could be addressed through developmentally sensitive, trauma-informed services, such as NMT. The results of this study suggest that the NMT might benefit adoptive families if greater attention is paid to implementation adherence, or fidelity.
Collapse
Affiliation(s)
- Kevin White
- School of Social Work, East Carolina University, Greenville, North Carolina, US
| | - Nancy Rolock
- Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, Ohio, US
| | - Erin Hambrick
- School of Education, Social Work and Psychological Sciences, University of Missouri-Kansas City, Kansas City, Missouri
| | - Rong Bai
- School of Social Work, East Carolina University, Greenville, North Carolina, US
- School of Social Work, Boston College, Boston, Massachusetts
| | - Anna Bender
- Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, Ohio, US
- Harborview Injury Prevention & Research Center, University of Washington, Seattle, Washington, US
| | - Kylie Evans
- Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, Ohio, US
- Breen School of Nursing and Health Professions, Ursuline College, Pepper Pike, Ohio, US
| | - Roni Diamant-Wilson
- Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, Ohio, US
| | | |
Collapse
|
4
|
Ranoa DRE, Sharma P, Schane CP, Lewis AN, Valdez E, Marada VVVR, Hager MV, Montgomery W, Wolf SP, Schreiber K, Schreiber H, Bailey K, Fan TM, Hergenrother PJ, Roy EJ, Kranz DM. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. J Immunother Cancer 2023; 11:e006509. [PMID: 37258040 PMCID: PMC10255004 DOI: 10.1136/jitc-2022-006509] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2023] [Indexed: 06/02/2023] Open
Abstract
BACKGROUND Treatment of some blood cancers with T cells that express a chimeric antigen receptor (CAR) against CD19 have shown remarkable results. In contrast, CAR-T cell efficacy against solid tumors has been difficult to achieve. METHODS To examine the potential of CAR-T cell treatments against ovarian cancers, we used the mouse ovarian cancer cell line ID8 in an intraperitoneal model that exhibits disseminated solid tumors in female C57BL/6J mice. The CAR contained a single-chain Fv from antibody 237 which recognizes a Tn-glycopeptide-antigen expressed by ID8 due to aberrant O-linked glycosylation in the absence of the transferase-dependent chaperone Cosmc. The efficacy of four Tn-dependent CARs with varying affinity to Tn antigen, and each containing CD28/CD3ζ cytoplasmic domains, were compared in vitro and in vivo in this study. RESULTS In line with many observations about the impact of aberrant O-linked glycosylation, the ID8Cosmc knock-out (ID8Cosmc-KO) exhibited more rapid tumor progression compared with wild-type ID8. Despite the enhanced tumor growth in vivo, 237 CAR and a mutant with 30-fold higher affinity, but not CARs with lower affinity, controlled advanced ID8Cosmc-KO tumors. Tumor regression could be achieved with a single intravenous dose of the CARs, but intraperitoneal administration was even more effective. The CAR-T cells persisted over a period of months, allowing CAR-treated mice to delay tumor growth in a re-challenge setting. The most effective CARs exhibited the highest affinity for antigen. Antitumor effects observed in vivo were associated with increased numbers of T cells and macrophages, and higher levels of cleaved caspase-3, in the tumor microenvironment. Notably, the least therapeutically effective CAR mediated tonic signaling leading to antigen-independent cytokine expression and it had higher levels of the immunosuppressive cytokine interleukin10. CONCLUSION The findings support the development of affinity-optimized CAR-T cells as a potential treatment for established ovarian cancer, with the most effective CARs mediating a distinct pattern of inflammatory cytokine release in vitro. Importantly, the most potent Tn-dependent CAR-T cells showed no evidence of toxicity in tumor-bearing mice in a syngeneic, immunocompetent system.
Collapse
Affiliation(s)
- Diana Rose E Ranoa
- Carl R. Woese Institute for Genomic Biology and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Preeti Sharma
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Claire P Schane
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Amber N Lewis
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Edward Valdez
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Venkata V V R Marada
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Marlies V Hager
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Will Montgomery
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Steven P Wolf
- Department of Pathology and David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA
| | - Karin Schreiber
- Department of Pathology and David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA
| | - Hans Schreiber
- Department of Pathology and David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA
| | - Keith Bailey
- Charles River Laboratories Inc Mattawan, Mattawan, Michigan, USA
| | - Timothy M Fan
- Carl R. Woese Institute for Genomic Biology and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Paul J Hergenrother
- Carl R. Woese Institute for Genomic Biology and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Edward J Roy
- Carl R. Woese Institute for Genomic Biology and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Department of Pathology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - David M Kranz
- Carl R. Woese Institute for Genomic Biology and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
- Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| |
Collapse
|
5
|
Zhang Y, Liu F, Zhang Y, Wang J, D’Andrea D, Walters JB, Li S, Yoon HJ, Wu M, Li S, Hu Z, Wang T, Choi J, Bailey K, Dempsey E, Zhao K, Lantsova A, Bouricha Y, Huang I, Guo H, Ni X, Wu Y, Lee G, Jiang F, Huang Y, Franz CK, Rogers JA. Self-powered, light-controlled, bioresorbable platforms for programmed drug delivery. Proc Natl Acad Sci U S A 2023; 120:e2217734120. [PMID: 36888661 PMCID: PMC10089205 DOI: 10.1073/pnas.2217734120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Accepted: 02/06/2023] [Indexed: 03/09/2023] Open
Abstract
Degradable polymer matrices and porous scaffolds provide powerful mechanisms for passive, sustained release of drugs relevant to the treatment of a broad range of diseases and conditions. Growing interest is in active control of pharmacokinetics tailored to the needs of the patient via programmable engineering platforms that include power sources, delivery mechanisms, communication hardware, and associated electronics, most typically in forms that require surgical extraction after a period of use. Here we report a light-controlled, self-powered technology that bypasses key disadvantages of these systems, in an overall design that is bioresorbable. Programmability relies on the use of an external light source to illuminate an implanted, wavelength-sensitive phototransistor to trigger a short circuit in an electrochemical cell structure that includes a metal gate valve as its anode. Consequent electrochemical corrosion eliminates the gate, thereby opening an underlying reservoir to release a dose of drugs by passive diffusion into surrounding tissue. A wavelength-division multiplexing strategy allows release to be programmed from any one or any arbitrary combination of a collection of reservoirs built into an integrated device. Studies of various bioresorbable electrode materials define the key considerations and guide optimized choices in designs. In vivo demonstrations of programmed release of lidocaine adjacent the sciatic nerves in rat models illustrate the functionality in the context of pain management, an essential aspect of patient care that could benefit from the results presented here.
Collapse
Affiliation(s)
- Yamin Zhang
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Fei Liu
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
| | - Yuhe Zhang
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Jin Wang
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
| | - Dominic D’Andrea
- Regenerative Neurorehabilitation Laboratory, Shirley Ryan Ability Lab, Chicago, IL60611
| | - Jordan B. Walters
- Regenerative Neurorehabilitation Laboratory, Shirley Ryan Ability Lab, Chicago, IL60611
| | - Shupeng Li
- Department of Mechanical Engineering, Northwestern University, Evanston, IL60208
| | - Hong-Joon Yoon
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Electronic Engineering, Gachon University, Seongnam-si, Gyeonggi-do13120, Republic of Korea
| | - Mingzheng Wu
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Neurobiology, Northwestern University, Evanston, IL60208
| | - Shuo Li
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Ziying Hu
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Tong Wang
- Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL60208
| | - Junhwan Choi
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Chemical Engineering, Dankook University, Yongin16890, Republic of Korea
| | | | - Elizabeth Dempsey
- Developmental Therapeutics Core, Northwestern University, Evanston, IL60208
| | - Kaiyu Zhao
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
| | - Anastasia Lantsova
- Department of Biomedical Engineering, Northwestern University, Evanston, IL60208
| | - Yasmine Bouricha
- Regenerative Neurorehabilitation Laboratory, Shirley Ryan Ability Lab, Chicago, IL60611
| | - Ivy Huang
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
| | - Hexia Guo
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
| | - Xinchen Ni
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Yunyun Wu
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Geumbee Lee
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
| | - Fuchang Jiang
- Department of Biomedical Engineering, Northwestern University, Evanston, IL60208
| | - Yonggang Huang
- Department of Mechanical Engineering, Northwestern University, Evanston, IL60208
| | - Colin K. Franz
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Regenerative Neurorehabilitation Laboratory, Shirley Ryan Ability Lab, Chicago, IL60611
- Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL60611
- The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL60611
| | - John A. Rogers
- Center for Bio-Integrated Electronics, Northwestern University, Evanston, IL60208
- Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL60208
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL60208
- Department of Mechanical Engineering, Northwestern University, Evanston, IL60208
- Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL60611
| |
Collapse
|
6
|
Saqib R, Madhavan A, Thornber E, Siripurapu R, Choi C, Holsgrove D, Bailey K, Thomas M, Hilditch CA. The value of performing cerebrovascular CT angiography in major trauma patients: a 5-year retrospective review. Clin Radiol 2023; 78:e190-e196. [PMID: 36646530 DOI: 10.1016/j.crad.2022.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 08/07/2022] [Accepted: 10/17/2022] [Indexed: 01/15/2023]
Abstract
AIM To assess whether routine cerebrovascular imaging is required in all major trauma (MT) patients. MATERIALS AND METHODS All MT patients with cerebrovascular imaging between January 2015 and December 2020 were included in the study. Data were collated regarding the type of indication for computed tomography (CT) angiography imaging, time interval from the initial trauma, relevant trauma diagnoses on initial trauma imaging, and CT angiography. Findings, such as aneurysms, vascular malformations, luminal thrombus, venous sinus thrombosis, or vascular injury, were collated. Subsequent treatment with anti-coagulants/anti-platelets or surgical/radiological intervention was noted. Follow-up imaging was assessed for residual injury or complications. RESULTS Two hundred and fifty of the 6,251 MT patients underwent dedicated cerebrovascular imaging and were included in the study. Of these 41 (16.4%) had cervical artery or venous sinus injury. Further positive vascular findings were identified in 25/250 patients who presented with an incidental stroke or a vascular abnormality and were mislabelled as MT patients at presentation. One patient with a carotid injury subsequently died following a large infarction. Another patient with vertebral artery injury suffered a non-lethal stroke. No patients underwent surgery or intervention. CONCLUSION The present study showed that the overall incidence of detected blunt cerebrovascular injuries was very low (0.6%) and even lower for symptomatic vascular injury (0.03%). Routine cerebrovascular imaging is not recommended in all MT trauma patients, but instead, a continued case-by-case basis should be considered.
Collapse
Affiliation(s)
- R Saqib
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK.
| | - A Madhavan
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - E Thornber
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - R Siripurapu
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - C Choi
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - D Holsgrove
- Department of Neurosurgery, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - K Bailey
- Department of Anaesthetics and Critical Care, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - M Thomas
- Department of Emergency Medicine, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| | - C A Hilditch
- Department of Neuroradiology, Salford Royal Hospital-Northern Care Alliance NHS Foundation Trust, Salford, UK
| |
Collapse
|
7
|
Schnelle AN, Huffman A, Masyr A, Bailey K. What is your diagnosis? Splenic mass aspirate from a cat. Vet Clin Pathol 2022; 51:609-611. [PMID: 35246847 DOI: 10.1111/vcp.13081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Revised: 09/02/2021] [Accepted: 10/05/2021] [Indexed: 12/24/2022]
Affiliation(s)
- Amy N Schnelle
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois, Urbana, IL, USA
| | - Amanda Huffman
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois, Urbana, IL, USA
| | - Alison Masyr
- Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL, USA
| | - Keith Bailey
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois, Urbana, IL, USA
| |
Collapse
|
8
|
Dean A, Jungwirth E, Bailey K, Panzitt K, Wagner M, Anakk S. RF03 | PMON288 Determining Mechanisms of Farnesoid×Receptor Regulation of Heme Biosynthesis and Ductular Reaction. J Endocr Soc 2022. [PMCID: PMC9627753 DOI: 10.1210/jendso/bvac150.1507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Bile acids are increasingly becoming recognized as hormones, and their main endogenous receptor is the farnesoid X receptor (FXR). In order to investigate whether FXR is necessary to maintain proliferation of the bile ducts in response to injury, we challenged male and female wild-type (WT) and Fxr knockout (FxrKO) mice with 0.1% 1,4 dihydro 2,4,6 trimethyl 3,5 pyridinediacarboxylic acid diethyl ester (DDC) in the diet for two weeks. DDC is an inhibitor of ferrochelatase, the final enzyme of heme biosynthesis, resulting in a buildup of bile plugs in the liver causing an inflammatory response called ductular reaction. We found that deletion of Fxr led to a dramatic reduction in the ductular reaction independent of the sex. Then we tested if the inhibition of ferrochelatase was compensated for in FxrKO mice by analyzing the expression of genes in the heme biosynthesis pathway. Although we find a decrease in basal Alad gene expression in FxrKO mice in both sexes, upon DDC treatment, expression does not decrease as much as seen in the WT mice. Intriguingly, we also noted sex-specific changes. Cpox expression was increased in male FxrKO mice, but FxrKO mice showed reduced suppression of Cpox expression when treated with DDC. Conversely, Ppox expression was reduced in male FxrKO mice compared to WT mice, and both male WT and FxrKO mice had a comparable reduction in Ppox expression upon DDC treatment. Female FxrKO mice showed a significant decrease in Fech expression basally that did not change with DDC treatment. These results suggest that FXR may contribute towards regulating expression of genes in the heme biosynthesis pathway. However, these observations do not explain the lack of ductular reaction. Since PGC1α was previously shown to control heme biosynthesis through its downstream targets, FOXO1 and NRF1, we examined their transcript expression in our study to determine if the pathway is playing a role in our observations. We examined this pathway and observed a significant decrease in Foxo1 expression in both sexes of WT and FxrKO mice basally but only a reduction in Nrf1 expression upon DDC treatment. We are currently investigating other potential regulators of heme biosynthesis and ductular reaction, such as Klf1 which regulates erythropoiesis and plays a role in ductular reaction and the nuclear receptors Rev-Erbα/β that use heme as a ligand, to determine how FXR is regulating heme biosynthesis. Presentation: Saturday, June 11, 2022 1:24 p.m. - 1:29 p.m., Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.
Collapse
|
9
|
Ebling R, Paim WP, Turner J, Flory G, Seiger J, Whitcomb C, Remmenga M, Vuolo M, Ramachandran A, Cole L, Flores EF, Miknis R, Brewer B, Miller L, Bailey K, Talley J, Bauermann FV. Virus viability in spiked swine bone marrow tissue during above-ground burial method and under in vitro conditions. Transbound Emerg Dis 2022; 69:2987-2995. [PMID: 35092641 PMCID: PMC9790394 DOI: 10.1111/tbed.14462] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 01/13/2022] [Accepted: 01/23/2022] [Indexed: 12/30/2022]
Abstract
The emergence of high consequence animal diseases usually requires managing significant mortality. A desirable aspect of any carcass management method is the ability to contain and inactivate the target pathogen. The above-ground burial (AGB) technique was recently developed and proposed as an alternative carcass management method. Here, we investigate the tenacity of swinepox virus (SwPV), as a surrogate model for African swine fever virus (ASFV) in swine carcasses during the AGB process. For this, SwPV was inoculated intrafemorally in 90 adult swine carcasses, which were subsequently disposed under AGB conditions. Bone marrow samples were recovered periodically throughout 12 months and virus viability was assessed by virus isolation (VI), whereas the presence of SwPV DNA was evaluated by quantitative polymerase chain reaction (qPCR). Additionally, an in vitro study assessed the inactivation rate of SwPV, Senecavirus A (SVA), and bovine viral diarrhoea virus (BVDV). Viral suspensions were mixed with bone marrow material and maintained at 21-23°C for 30 days. Virus viability was assessed by VI and viral titration. In the field study, SwPV remained viable only in 11 (55%) bone marrow samples collected on day 7; only viral DNA (and not infectivity) was detected afterwards. SwPV inactivation was estimated to have occurred by day 11. The in vitro testing revealed a variable tenacity of the studied viruses. The viability period was estimated in 28, 80, and 118 days, respectively, for BVDV, SwPV, and SVA. Overall, these findings indicate that the AGB technique was effective in quickly inactivating SwPV. Additionally, the SwPV inactivation rate is comparable to ASFV under field studies and poses a potential model for preliminary ASFV inactivation studies with reduced biosecurity requirements. Moreover, this study contributes to understanding the inactivation kinetics of viruses under specific conditions, which is critical when designing and applying countermeasures in case of biosecurity breaches in sites managing animal mortality.
Collapse
Affiliation(s)
- Rafael Ebling
- Department of Veterinary PathobiologyCollege of Veterinary MedicineOklahoma State UniversityStillwaterOklahomaUSA,Setor de VirologiaUniversidade Federal de Santa MariaSanta MariaBrazil
| | - Willian Pinto Paim
- Department of Veterinary PathobiologyCollege of Veterinary MedicineOklahoma State UniversityStillwaterOklahomaUSA,Laboratório de VirologiaFaculdade de VeterináriaUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
| | - Justin Turner
- Department of Entomology & Plant PathologyFerguson College of AgricultureOklahoma State UniversityStillwaterOklahomaUSA
| | - Gary Flory
- G.A. Flory ConsultingMt. CrawfordVirginiaUSA,Virginia Department of Environmental QualityHarrisonburgVirginiaUSA
| | - Jeremy Seiger
- Envirotech Engineering & Consulting, Inc.Oklahoma CityOklahomaUSA
| | - Caleb Whitcomb
- Oklahoma Department of Agriculture, Food and ForestryOklahoma CityOklahomaUSA
| | - Marta Remmenga
- Center for Epidemiology and Animal Health, Veterinary ServicesU.S. Department of AgricultureAnimal and Plant Health Inspection ServicesFort CollinsColoradoUSA
| | - Matthew Vuolo
- Center for Epidemiology and Animal Health, Veterinary ServicesU.S. Department of AgricultureAnimal and Plant Health Inspection ServicesFort CollinsColoradoUSA
| | - Akhilesh Ramachandran
- Molecular Diagnostic LaboratoryOklahoma Animal Disease Diagnostic LaboratoryOklahoma State UniversityStillwaterOklahomaUSA
| | - Leslie Cole
- United States Department of AgricultureAnimal and Plant Health Inspection ServiceVeterinary ServicesField OperationsOklahoma CityOklahomaUSA
| | | | - Robert Miknis
- U.S. Department of AgricultureAnimal and Plant Health Inspection ServicesFort CollinsColoradoUSA
| | - Becky Brewer
- United States Department of AgricultureAnimal and Plant Health Inspection ServiceVeterinary ServicesField OperationsOklahoma CityOklahomaUSA
| | - Lori Miller
- United States Department of Agriculture Animal and Plant Health Inspection Service Veterinary ServicesStrategy and PolicyRiverdaleMarylandUSA
| | - Keith Bailey
- Molecular Diagnostic LaboratoryOklahoma Animal Disease Diagnostic LaboratoryOklahoma State UniversityStillwaterOklahomaUSA,Charles River LaboratoriesMattawanMichiganUSA
| | - Justin Talley
- Department of Entomology & Plant PathologyFerguson College of AgricultureOklahoma State UniversityStillwaterOklahomaUSA
| | - Fernando Vicosa Bauermann
- Department of Veterinary PathobiologyCollege of Veterinary MedicineOklahoma State UniversityStillwaterOklahomaUSA
| |
Collapse
|
10
|
Shaw RPH, Kolyvas P, Dang N, Hyon A, Bailey K, Anakk S. Loss of Hepatic Small Heterodimer Partner Elevates Ileal Bile Acids and Alters Cell Cycle-related Genes in Male Mice. Endocrinology 2022; 163:6572176. [PMID: 35451003 PMCID: PMC9113360 DOI: 10.1210/endocr/bqac052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Indexed: 11/19/2022]
Abstract
Small heterodimer partner (Shp) regulates several metabolic processes, including bile acid levels, but lacks the conserved DNA binding domain. Phylogenetic analysis revealed conserved genetic evolution of SHP, FXR, CYP7A1, and CYP8B1. Shp, although primarily studied as a downstream target of Farnesoid X Receptor (Fxr), has a distinct hepatic role that is poorly understood. Here, we report that liver-specific Shp knockout (LShpKO) mice have impaired negative feedback of Cyp7a1 and Cyp8b1 on bile acid challenge and demonstrate that a single copy of the Shp gene is sufficient to maintain this response. LShpKO mice also exhibit elevated total bile acid pool with ileal bile acid composition mimicking that of cholic acid-fed control mice. Agonistic activation of Fxr (GW4064) in the LShpKO did not alter the elevated basal expression of Cyp8b1 but lowered Cyp7a1 expression. We found that deletion of Shp led to an enrichment of distinct motifs and pathways associated with circadian rhythm, copper ion transport, and DNA synthesis. We confirmed increased expression of metallothionein genes that can regulate copper levels in the absence of SHP. LShpKO livers also displayed a higher basal proliferation that was exacerbated specifically with bile acid challenge either with cholic acid or 3,5-diethoxycarbonyl-1,4-dihydrocollidine but not with another liver mitogen, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene. Overall, our data indicate that hepatic SHP uniquely regulates certain proliferative and metabolic cues.
Collapse
Affiliation(s)
| | - Peter Kolyvas
- Department of Molecular and Integrative Physiology, Urbana, IL 61801, USA
| | - Nathanlown Dang
- Department of Molecular and Integrative Physiology, Urbana, IL 61801, USA
| | - Angela Hyon
- Department of Molecular and Integrative Physiology, Urbana, IL 61801, USA
| | - Keith Bailey
- Veterinary Diagnostic Laboratory, Urbana, IL 61801, USA
| | - Sayeepriyadarshini Anakk
- Department of Molecular and Integrative Physiology, Urbana, IL 61801, USA
- Beckman Institute for Advanced Science and Technology, Urbana, IL 61801, USA
- Division of Nutritional Sciences, Urbana, IL 61801, USA
- Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
- Correspondence: Sayeepriyadarshini Anakk, PhD, Department of Molecular and Integrative Physiology, Beckman Institute for Advanced Science and Technology, Division of Nutritional Sciences, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, USA. E-mail:
| |
Collapse
|
11
|
Liu H, Vohra N, Bailey K, El-Shenawee M, Nelson AH. Deep Learning Classification of Breast Cancer Tissue from Terahertz Imaging Through Wavelet Synchro-Squeezed Transformation and Transfer Learning. J Infrared Millim Terahertz Waves 2022; 43:48-70. [PMID: 36246840 PMCID: PMC9558445 DOI: 10.1007/s10762-021-00839-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Accepted: 12/21/2021] [Indexed: 05/25/2023]
Abstract
Terahertz imaging and spectroscopy is an exciting technology that has the potential to provide insights in medical imaging. Prior research has leveraged statistical inference to classify tissue regions from terahertz images. To date, these approaches have shown that the segmentation problem is challenging for images of fresh tissue and for tumors that have invaded muscular regions. Artificial intelligence, particularly machine learning and deep learning, has been shown to improve performance in some medical imaging challenges. This paper builds on that literature by modifying a set of deep learning approaches to the challenge of classifying tissue regions of images captured by terahertz imaging and spectroscopy of freshly excised murine xenograft tissue. Our approach is to preprocess the images through a wavelet synchronous-squeezed transformation (WSST) to convert time-sequential terahertz data of each THz pixel to a spectrogram. Spectrograms are used as input tensors to a deep convolution neural network for pixel-wise classification. Based on the classification result of each pixel, a cancer tissue segmentation map is achieved. In experimentation, we adopt leave-one-sample-out cross-validation strategy, and evaluate our chosen networks and results using multiple metrics such as accuracy, precision, intersection, and size. The results from this experimentation demonstrate improvement in classification accuracy compared to statistical methods, an improvement to segmentation between muscle and cancerous regions in xenograft tumors, and identify areas to improve the imaging and classification methodology.
Collapse
Affiliation(s)
- Haoyan Liu
- Department of Computer Science and Computer Engineering, University of Arkansas, Fayetteville, AR, 72701, USA
| | - Nagma Vohra
- Department of Electrical Engineering, University of Arkansas, Fayetteville, AR 72701, USA
| | - Keith Bailey
- Charles River Laboratories, Mattawan, MI, 49071, USA
| | - Magda El-Shenawee
- Department of Electrical Engineering, University of Arkansas, Fayetteville, AR 72701, USA
| | - Alexander H. Nelson
- Department of Computer Science and Computer Engineering, University of Arkansas, Fayetteville, AR, 72701, USA
| |
Collapse
|
12
|
Vohra N, Liu H, Nelson AH, Bailey K, El-Shenawee M. Hyperspectral terahertz imaging and optical clearance for cancer classification in breast tumor surgical specimen. J Med Imaging (Bellingham) 2022; 9:014002. [PMID: 35036473 PMCID: PMC8752447 DOI: 10.1117/1.jmi.9.1.014002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Accepted: 12/21/2021] [Indexed: 01/14/2023] Open
Abstract
Purpose: We investigate the enhancement in terahertz (THz) images of freshly excised breast tumors upon treatment with an optical clearance agent. The hyperspectral imaging and spectral classifications are used to quantitatively demonstrate the image enhancement. Glycerol solution with 60% concentration is applied to excised breast tumor specimens for various time durations to investigate the effectiveness on image enhancement. Approach: THz reflection spectroscopy is utilized to obtain the absorption coefficient and the index of refraction of untreated and glycerol-treated tissues at each frequency up to 3 THz. Two classifiers, spectral angular mapping (SAM) based on several kernels and Euclidean minimum distance (EMD) are implemented to evaluate the effectiveness of the treatment. The testing raw data is obtained from five breast cancer specimens: two untreated specimens and three specimens treated with glycerol solution for 20, 40, or 60 min. All tumors used in the testing data have healthy tissues adjacent to cancerous ones consistent with the challenge faced in lumpectomy surgeries. Results: The glycerol-treated tissues showed a decrease in the absorption coefficients compared with untreated tissues, especially as the period of treatment increased. Although the sensitivity metric of the classifier presented higher values in the untreated tissues compared with the treated ones, the specificity and accuracy metrics demonstrated higher values for the treated tissues compared with the untreated ones. Conclusions: The biocompatible glycerol solution is a potential optical clearance agent in THz imaging while keeping the histopathology imaging intact. The SAM technique provided a good classification of cancerous tissues despite the small amount of cancer in the training data (only 7%). The SAM exponential kernel and EMD presented classification accuracy of ∼ 80 % to 85% compared with linear and polynomial kernels that provided accuracy ranging from 70% to 80%. Overall, glycerol treatment provides a potential improvement in cancer classification in freshly excised breast tumors.
Collapse
Affiliation(s)
- Nagma Vohra
- University of Arkansas, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Haoyan Liu
- University of Arkansas, Department of Computer Science and Engineering, Fayetteville, Arkansas, United States
| | - Alexander H. Nelson
- University of Arkansas, Department of Computer Science and Engineering, Fayetteville, Arkansas, United States
| | - Keith Bailey
- Charles River Laboratory, Mattawan, Michigan, United States
| | - Magda El-Shenawee
- University of Arkansas, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| |
Collapse
|
13
|
Chavez T, Vohra N, Bailey K, El-Shenawee M, Wu J. Supervised Bayesian learning for breast cancer detection in terahertz imaging. Biomed Signal Process Control 2021. [DOI: 10.1016/j.bspc.2021.102949] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
Hao L, Chen C, Bailey K, Wang L. Bovine kobuvirus-A comprehensive review. Transbound Emerg Dis 2021; 68:1886-1894. [PMID: 33146459 DOI: 10.1111/tbed.13909] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 10/14/2020] [Accepted: 10/30/2020] [Indexed: 02/05/2023]
Abstract
Bovine kobuvirus (BKV) is a single-stranded, positive sense, non-enveloped RNA virus in genus Kobuvirus of family Picornavirus. BKV was first identified in the culture media of HeLa cell containing calf serum in 2003. Since then, BKV has been detected in 13 countries of four different continents, suggesting widespread in the world. Herein, we review the detection and genomic characterization of BKV in 13 countries. All studies tested bovine faecal samples for BKV. These studies provide evidence that BKV might be a causative agent for neonatal calf diarrhoea. Therefore, further efforts including animal challenge study are urgently needed to unveil the pathogenicity of BKV.
Collapse
Affiliation(s)
- Lili Hao
- College of Life Science and Technology, Southwest Minzu University, Chengdu, China
| | - Chaoxi Chen
- College of Life Science and Technology, Southwest Minzu University, Chengdu, China
| | - Keith Bailey
- Department of Veterinary Clinical Medicine and the Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA
| | - Leyi Wang
- Department of Veterinary Clinical Medicine and the Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA
| |
Collapse
|
15
|
Vohra N, Chavez T, Troncoso JR, Rajaram N, Wu J, Coan PN, Jackson TA, Bailey K, El-Shenawee M. Mammary tumors in Sprague Dawley rats induced by N-ethyl-N-nitrosourea for evaluating terahertz imaging of breast cancer. J Med Imaging (Bellingham) 2021; 8:023504. [PMID: 33928181 DOI: 10.1117/1.jmi.8.2.023504] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2020] [Accepted: 03/31/2021] [Indexed: 11/14/2022] Open
Abstract
Purpose: The objective of this study is to quantitatively evaluate terahertz (THz) imaging for differentiating cancerous from non-cancerous tissues in mammary tumors developed in response to injection of N-ethyl-N-nitrosourea (ENU) in Sprague Dawley rats. Approach: While previous studies have investigated the biology of mammary tumors of this model, the current work is the first study to employ an imaging modality to visualize these tumors. A pulsed THz imaging system is utilized to experimentally collect the time-domain reflection signals from each pixel of the rat's excised tumor. A statistical segmentation algorithm based on the expectation-maximization (EM) classification method is implemented to quantitatively assess the obtained THz images. The model classification of cancer is reported in terms of the receiver operating characteristic (ROC) curves and the areas under the curves. Results: The obtained low-power microscopic images of 17 ENU-rat tumor sections exhibited the presence of healthy connective tissue adjacent to cancerous tissue. The results also demonstrated that high reflection THz signals were received from cancerous compared with non-cancerous tissues. Decent tumor classification was achieved using the EM method with values ranging from 83% to 96% in fresh tissues and 89% to 96% in formalin-fixed paraffin-embedded tissues. Conclusions: The proposed ENU breast tumor model of Sprague Dawley rats showed a potential to obtain cancerous tissues, such as human breast tumors, adjacent to healthy tissues. The implemented EM classification algorithm quantitatively demonstrated the ability of THz imaging in differentiating cancerous from non-cancerous tissues.
Collapse
Affiliation(s)
- Nagma Vohra
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Tanny Chavez
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Joel R Troncoso
- University of Arkansas, Bell Engineering Center, Department of Biomedical Engineering, Fayetteville, Arkansas, United States
| | - Narasimhan Rajaram
- University of Arkansas, Bell Engineering Center, Department of Biomedical Engineering, Fayetteville, Arkansas, United States
| | - Jingxian Wu
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Patricia N Coan
- Oklahoma State University, Animal Resources Unit, Stillwater, Oklahoma, United States
| | - Todd A Jackson
- Oklahoma State University, Animal Resources Unit, Stillwater, Oklahoma, United States
| | - Keith Bailey
- University of Illinois, Urbana-Champaign, Veterinary Diagnostic Laboratory, Urbana, Illinois, United States
| | - Magda El-Shenawee
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| |
Collapse
|
16
|
Barger AM, Welle K, Athey JM, Hamel P, Bailey K. What is your diagnosis? A coelomic mass in a duck. Vet Clin Pathol 2020; 49:684-685. [PMID: 33381871 DOI: 10.1111/vcp.12910] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Revised: 04/21/2020] [Accepted: 05/05/2020] [Indexed: 11/27/2022]
Affiliation(s)
- Anne M Barger
- Department of Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
| | - Kenneth Welle
- Department of Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
| | - Jillian M Athey
- Department of Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
| | - Philip Hamel
- Department of Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
| | - Keith Bailey
- Department of Veterinary Clinical Medicine, University of Illinois, Urbana, IL, USA
| |
Collapse
|
17
|
Lawler J, Choynowski M, Bailey K, Bucholc M, Johnston A, Sugrue M. Meta-analysis of the impact of postoperative infective complications on oncological outcomes in colorectal cancer surgery. BJS Open 2020; 4:737-747. [PMID: 32525280 PMCID: PMC7528523 DOI: 10.1002/bjs5.50302] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 02/26/2020] [Accepted: 05/02/2020] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Cancer outcomes are complex, involving prevention, early detection and optimal multidisciplinary care. Postoperative infection and surgical site-infection (SSI) are not only uncomfortable for patients and costly, but may also be associated with poor oncological outcomes. A meta-analysis was undertaken to assess the oncological effects of SSI in patients with colorectal cancer. METHODS An ethically approved PROSPERO-registered meta-analysis was conducted following PRISMA guidelines. PubMed and Scopus databases were searched for studies published between 2007 and 2017 reporting the effects of postoperative infective complications on oncological survival in colorectal cancer. Results were separated into those for SSI and those concerning anastomotic leakage. Articles with a Methodological Index for Non-Randomized Studies score of at least 18 were included. Hazard ratios (HRs) with 95 per cent confidence intervals were computed for risk factors using an observed to expected and variance fixed-effect model. RESULTS Of 5027 articles were reviewed, 43 met the inclusion criteria, with a total of 154 981 patients. Infective complications had significant negative effects on overall survival (HR 1·37, 95 per cent c.i. 1·28 to 1·46) and cancer-specific survival (HR 2·58, 2·15 to 3·10). Anastomotic leakage occurred in 7·4 per cent and had a significant negative impact on disease-free survival (HR 1·14, 1·09 to 1·20), overall survival (HR 1·34, 1·28 to 1·39), cancer-specific survival (HR 1·43, 1·31 to 1·55), local recurrence (HR 1·18, 1·06 to 1·32) and overall recurrence (HR 1·46, 1·27 to 1·68). CONCLUSION This meta-analysis identified a significant negative impact of postoperative infective complications on overall and cancer-specific survival in patients undergoing colorectal surgery.
Collapse
Affiliation(s)
- J Lawler
- Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Donegal, Ireland
| | - M Choynowski
- Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Donegal, Ireland
| | - K Bailey
- Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Donegal, Ireland
| | - M Bucholc
- EU INTERREG Centre for Personalized Medicine, Intelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Magee Campus, Derry, /Londonderry, UK
| | - A Johnston
- Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Donegal, Ireland
| | - M Sugrue
- Department of Surgery, Letterkenny University Hospital and Donegal Clinical Research Academy, Donegal, Ireland.,EU INTERREG Centre for Personalized Medicine, Intelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Magee Campus, Derry, /Londonderry, UK
| |
Collapse
|
18
|
Abstract
This manuscript presents a protocol to handle, characterize, and image freshly excised human breast tumors using pulsed terahertz imaging and spectroscopy techniques. The protocol involves terahertz transmission mode at normal incidence and terahertz reflection mode at an oblique angle of 30°. The collected experimental data represent time domain pulses of the electric field. The terahertz electric field signal transmitted through a fixed point on the excised tissue is processed, through an analytical model, to extract the refractive index and absorption coefficient of the tissue. Utilizing a stepper motor scanner, the terahertz emitted pulse is reflected from each pixel on the tumor providing a planar image of different tissue regions. The image can be presented in time or frequency domain. Furthermore, the extracted data of the refractive index and absorption coefficient at each pixel are utilized to provide a tomographic terahertz image of the tumor. The protocol demonstrates clear differentiation between cancerous and healthy tissues. On the other hand, not adhering to the protocol can result in noisy or inaccurate images due to the presence of air bubbles and fluid remains on the tumor surface. The protocol provides a method for surgical margins assessment of breast tumors.
Collapse
Affiliation(s)
- Nagma Vohra
- Department of Electrical Engineering, University of Arkansas;
| | - Tyler Bowman
- Department of Electrical Engineering, University of Arkansas
| | - Keith Bailey
- Oklahoma Animal Disease Diagnostic Laboratory, Oklahoma State University
| | | |
Collapse
|
19
|
Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus 2020; 29:474-481. [PMID: 32233733 PMCID: PMC7528537 DOI: 10.1177/0961203320909156] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Background Systemic lupus erythematous (SLE) is a systemic autoimmune/inflammatory condition. Approximately 15–20% of patients develop symptoms before their 18th birthday and are diagnosed with juvenile-onset SLE (JSLE). Gender distribution, clinical presentation, disease courses and outcomes vary significantly between JSLE patients and individuals with adult-onset SLE. This study aimed to identify age-specific clinical and/or serological patterns in JSLE patients enrolled to the UK JSLE Cohort Study. Methods Patient records were accessed and grouped based on age at disease-onset: pre-pubertal (≤7 years), peri-pubertal (8–13 years) and adolescent (14–18 years). The presence of American College of Rheumatology (ACR) classification criteria, laboratory results, disease activity [British Isles Lupus Assessment Group (BILAG) and Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2 K) scores] and damage [Systemic Lupus International Collaborating Clinics (SLICC) damage index] were evaluated at diagnosis and last follow up. Results A total of 418 JSLE patients were included in this study: 43 (10.3%) with pre-pubertal disease onset; 240 (57.4%) with peri-pubertal onset and 135 (32.3%) were diagnosed during adolescence. At diagnosis, adolescent JSLE patients presented with a higher number of ACR criteria when compared with pre-pubertal and peri-pubertal patients [pBILAG2004 scores: 9(4–20] vs. 7(3–13] vs. 7(3–14], respectively, p = 0.015] with increased activity in the following BILAG domains: mucocutaneous (p = 0.025), musculoskeletal (p = 0.029), renal (p = 0.027) and cardiorespiratory (p = 0.001). Furthermore, adolescent JSLE patients were more frequently ANA-positive (p = 0.034) and exhibited higher anti-dsDNA titres (p = 0.001). Pre-pubertal individuals less frequently presented with leukopenia (p = 0.002), thrombocytopenia (p = 0.004) or low complement (p = 0.002) when compared with other age groups. No differences were identified in disease activity (pBILAG2004 score), damage (SLICC damage index) and the number of ACR criteria fulfilled at last follow up. Conclusions Disease presentations and laboratory findings vary significantly between age groups within a national cohort of JSLE patients. Patients diagnosed during adolescence exhibit greater disease activity and “classic” autoantibody, immune cell and complement patterns when compared with younger patients. This supports the hypothesis that pathomechanisms may vary between patient age groups.
Collapse
Affiliation(s)
- J S Massias
- School of Medicine, University of Liverpool, UK
| | - E M D Smith
- Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, UK.,Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, UK
| | - E Al-Abadi
- Department of Rheumatology, Birmingham Children's Hospital, Birmingham, UK
| | - K Armon
- Department of Paediatric Rheumatology, Cambridge University Hospitals, Cambridge, UK
| | - K Bailey
- Department of Paediatric Rheumatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - C Ciurtin
- Department of Rheumatology, University College London Hospitals NHS Foundation Trust, London, UK
| | - J Davidson
- Department of Paediatric Rheumatology, Royal Hospital for Sick Children, Edinburgh, UK
| | | | - K Haslam
- Department of Paediatrics, Bradford Royal Infirmary, Bradford, UK
| | - D P Hawley
- Department of Paediatric Rheumatology, Sheffield Children's Hospital, Sheffield, UK
| | - A Leahy
- Department of Paediatric Rheumatology, Southampton General Hospital, Southampton, UK
| | - V Leone
- Department of Paediatric Rheumatology, Leeds Children Hospital, Leeds, UK
| | - F McErlane
- Paediatric Rheumatology, Great North Children's Hospital, Royal Victoria Infirmary, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - D Mewar
- Department of Rheumatology, Royal Liverpool University Hospital, Liverpool, UK
| | - G Modgil
- Department of Paediatrics, Musgrove Park Hospital, Taunton, UK
| | - R Moots
- Department of Rheumatology, University Hospital Aintree, Liverpool, UK
| | - C Pilkington
- Department of Paediatric Rheumatology, Great Ormond Street Hospital, London, UK
| | - A V Ramanan
- University Hospitals Bristol NHS Foundation Trust & Bristol Medical School, University of Bristol, Bristol, UK
| | - S Rangaraj
- Department of Paediatric Rheumatology, Nottingham University Hospitals Nottingham, UK
| | - P Riley
- Department of Paediatric Rheumatology, Royal Manchester Children's Hospital, Manchester, UK
| | - A Sridhar
- Department of Paediatrics, Leicester Royal Infirmary, Leicester, UK
| | - N Wilkinson
- Guy's & St Thomas's NHS Foundation Trust, Evelina Children's Hospital, London, UK
| | - M W Beresford
- Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, UK.,Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, UK
| | - C M Hedrich
- Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, UK.,Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, UK
| |
Collapse
|
20
|
Chavez T, Vohra N, Wu J, Bailey K, El-Shenawee M. Breast Cancer Detection with Low-dimension Ordered Orthogonal Projection in Terahertz Imaging. IEEE Trans Terahertz Sci Technol 2020; 10:176-189. [PMID: 33747610 PMCID: PMC7977298 DOI: 10.1109/tthz.2019.2962116] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
This paper proposes a new dimension reduction algorithm based on low-dimension ordered orthogonal projection (LOOP), which is used for cancer detection with terahertz (THz) images of freshly excised human breast cancer tissues. A THz image can be represented by a data cube with each pixel containing a high dimension spectrum vector covering several THz frequencies, where each frequency represents a different dimension in the vector. The proposed algorithm projects the high-dimension spectrum vector of each pixel within the THz image into a low-dimension subspace that contains the majority of the unique features embedded in the image. The low-dimension subspace is constructed by sequentially identifying its orthonormal basis vectors, such that each newly chosen basis vector represents the most unique information not contained by existing basis vectors. A multivariate Gaussian mixture model is used to represent the statistical distributions of the low-dimension feature vectors obtained from the proposed dimension reduction algorithm. The model parameters are iteratively learned by using unsupervised learning methods such as Markov chain Monte Carlo or expectation maximization, and the results are used to classify the various regions within a tumor sample. Experiment results demonstrate that the proposed method achieves apparent performance improvement in human breast cancer tissue over existing approaches such as one-dimension Markov chain Monte Carlo. The results confirm that the dimension reduction algorithm presented in this paper is a promising technique for breast cancer detection with THz images, and the classification results present a good correlation with respect to the histopathology results of the analyzed samples.
Collapse
Affiliation(s)
- Tanny Chavez
- Electrical Engineering Department, University of Arkansas, Fayetteville, AR 72701 USA
| | - Nagma Vohra
- Electrical Engineering Department, University of Arkansas, Fayetteville, AR 72701 USA
| | - Jingxian Wu
- Electrical Engineering Department, University of Arkansas, Fayetteville, AR 72701 USA
| | - Keith Bailey
- University of Illinois at Urbana-Champaign, Veterinary Diagnostic Laboratory, Urbana, IL 61802
| | - Magda El-Shenawee
- Electrical Engineering Department, University of Arkansas, Fayetteville, AR 72701 USA
| |
Collapse
|
21
|
Abstract
Abstract
The identity of samples of 2-, 3-, and 4-methoxyamphetamine and 2-, 3-, and 4-methylamphetamine is conclusively established by comparison of their spectra. Ultraviolet, proton magnetic resonance, and mass spectra distinguish and identify the 2 series and infrared spectra differentiate isomers; reference spectra and data are provided. Thin layer and gas-liquid chromatographic systems suitable for distinguishing these compounds are described.
Collapse
Affiliation(s)
- Keith Bailey
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A OL2
| | - Harry D Beckstead
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A OL2
| | - Donald Legault
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A OL2
| | - Denise Verner
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A OL2
| |
Collapse
|
22
|
Abstract
Abstract
The drugs 1-[1-(2-thienyl)cyclohexyl]piperidine, 1-[1-(2-thienyl) cyclohexyl] morpholine, 1-[1-(2-thienyl)cyclohexyl] pyrrolidine, 1-(1-phenylcyclohexyl) morpholine, and 1-(1-phenylcyclohexyl) pyrrolidine are identified by spectroscopic techniques. The ultraviolet and proton magnetic resonance spectra of analogs are similar, but mass and infrared spectra are distinctly different, and reference spectra are provided. Gas-liquid and thin layer chromatographic systems for the analysis are discussed.
Collapse
Affiliation(s)
- Keith Bailey
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A 0L2
| | - Denise R Gagné
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A 0L2
| | - Richard K Pike
- Drug Research Laboratories, Health Protection Branch, Tunney’s Pasture, Ottawa, Ontario, Canada K1A 0L2
| |
Collapse
|
23
|
Nagele M, Bailey K, Kolessar M, O'Neill T, Yetkin Z. A-37 Effects of Atypical Language Representation in Populations Suffering From Intractable Epilepsy. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz034.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
Atypical language laterality, secondary to refractory epilepsy, presents complications to surgical planning/cognitive outcomes. Extant research shows the non-dominant hemisphere reallocates neural resources for language compensation in response to left-sided lesions (resulting in decreased visuoperceptual/visual memory). The present study examined relationships between 1) lesion location and atypical language organization and 2) lesion location/language laterality on performance on memory (California Verbal Memory Test 2nd-edition (CVLT; Delayed Recall), and visuoperceptual (Rey-Osterrieth Complex Figure Test, ROCFT; Copy) tests in relation to lesion location in a sample of patients with intractable epilepsy.
Method
Retrospective data was compiled on patients with refractory epilepsy undergoing interdisciplinary pre-surgical workup (N = 101), mean age of 37.2 (SD = 11.9) and mean education of 12.3 (SD = 3.7). The sample was then stratified by non-lesional (n = 48), left (n = 26), right (n = 21) or bilateral (n = 6) mesial temporal sclerosis (MTL); and, language laterality was confirmed by neuroradiologists via functional Magnetic Resonance Imaging (fMRI) scans.
Results
Analyses showed patients with left MTS were more likely to have atypical language organization, X2 (1, N = 47) = 6.6, p = .01. Moreover, significant differences on T-scores for CVLT, F (3,15) = 3.81, p = .04, 95% Cl [-1.73, -.08] and ROCFT, F(4,28) = 2.85, p = .046 95% Cl [31.62, 46.17] were found between groups stratified by lesion location/language laterality, respectively.
Conclusions
Organization of language in epileptic populations presents atypically in conjunction with left-sided lesions. Additionally, cognitive processes such as verbal memory and visuoperceptual abilities suffer based on lesion presence/location and language laterality in this fMRI confirmed sample.
Collapse
|
24
|
Hernandez AA, Foster GA, Dai Y, Rivara KR, Bailey K, Singh GD, Simon SI. Monocyte activation in cardiovascular disease through inflammatory signaling associated with CD11c function. The Journal of Immunology 2019. [DOI: 10.4049/jimmunol.202.supp.51.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
Circulating monocytes are critical in the development and progression of atherosclerotic disease. During disease, prolonged metabolic dysregulation and low-grade inflammation promote monocytosis and subsequent skewing of the circulating monocyte repertoire to favor an expanded frequency of intermediate monocytes (CD14+CD16+CCR2, iMo). Intermediate monocytes display a hallmark upregulation of β2-integrin CD11c/CD18 which works in cooperation with β1-integrin VLA-4 to mediate monocyte capture and firm arrest to endothelial VCAM-1 at sites of disturbed flow at sites of nascent plaque. Notably, the expanded frequency, quantity of iMo CD11c receptors, and CD11c/VLA-4 dependent arrest of iMo to VCAM-1 gauge the severity of cardiovascular disease and are predictive of poor clinical outcome. Using these observations, we sought to examine the functional activity of arrested iMo on a substrate of VCAM-1 under arterial shear stress through the assessment of CD11c outside-in signaling using microfluidic platforms. We find that iMo undergo rapid transmigration (~90sec) at near 100% efficiency following by characteristic ADAM17 dependent shedding of CD16 that coincided with nuclear translocation of NFκβ, and elaboration of intracellular MMP-9 and IL-1β inflammatory molecules. Phenotypic conversion towards activated M1-like macrophages was governed by an allosteric shift in CD11c from high to low affinity on a majority of adherent iMo from CAD and NSTEMI patients, but not those from age-matched healthy subjects. We conclude that CD11c is a molecular biomarker and functionally relevant inflammatory signaling molecule on iMo. Its expression and function provides the most sensitive measure for diagnosing progression of CAD to MI.
Collapse
|
25
|
Bowman T, Vohra N, Bailey K, El-Shenawee M. Terahertz tomographic imaging of freshly excised human breast tissues. J Med Imaging (Bellingham) 2019; 6:023501. [PMID: 31093516 PMCID: PMC6514326 DOI: 10.1117/1.jmi.6.2.023501] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2018] [Accepted: 04/15/2019] [Indexed: 12/14/2022] Open
Abstract
Terahertz imaging and spectroscopy characterization of freshly excised breast cancer tumors are presented in the range 0.15 to 3.5 THz. Cancerous breast tissues were obtained from partial or full removal of malignant tumors while healthy breast tissues were obtained from breast reduction surgeries. The reflection spectroscopy to obtain the refractive index and absorption coefficient is performed on experimental data at each pixel of the tissue, forming tomographic images. The transmission spectroscopy of the refractive index and absorption coefficient are retrieved from experimental data at few tissue points. The average refractive index and absorption coefficients for cancer, fat, and collagen tissue regions are compared between transmission and reflection modes. The reflection mode offers the advantage of retrieving the electrical properties across a significantly greater number of points without the need for sectioning or altering the freshly excised tissue as in the transmission mode. The terahertz spectral power images and the tomographic images demonstrated good qualitative comparison with pathology.
Collapse
Affiliation(s)
- Tyler Bowman
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Nagma Vohra
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Keith Bailey
- Oklahoma State University, Oklahoma Animal Disease Diagnostic Laboratory, Stillwater, Oklahoma, United States
| | - Magda El-Shenawee
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| |
Collapse
|
26
|
Anderson KB, Meinkoth J, Hallman M, Bailey K, Brandão J. Cytological Diagnosis of Gastric Neuroendocrine Carcinoma in a Pet Inland Bearded Dragon (Pogona Vitticeps). J Exot Pet Med 2019. [DOI: 10.1053/j.jepm.2018.09.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
27
|
Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus 2019; 28:613-620. [DOI: 10.1177/0961203319836712] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Background Juvenile-onset systemic lupus erythematosus (JSLE) is more severe than adult-onset disease, including more lupus nephritis (LN). Despite differences in phenotype/pathogenesis, treatment is based upon adult trials. This study aimed to compare treatment response, damage accrual, time to inactive LN and subsequent flare, in JSLE LN patients treated with mycophenolate mofetil (MMF) versus intravenous cyclophosphamide (IVCYC). Methods UK JSLE Cohort Study participants, ≤16 years at diagnosis, with ≥4 American College of Rheumatology criteria for SLE, with class III or IV LN, were eligible. Mann–Whitney U tests, Fisher's exact test and Chi-squared tests were utilized for statistical analysis. Results Of the patients, 34/51 (67%) received MMF, and 17/51 (33%) received IVCYC. No significant differences were identified at 4–8 and 10–14 months post-renal biopsy and last follow-up, in terms of renal British Isles Lupus Assessment Grade scores, urine albumin/creatinine ratio, serum creatinine, ESR, anti-dsDNA antibody, C3 levels and patient/physician global scores. Standardized Damage Index scores did not differ between groups at 13 months or at last follow-up. Inactive LN was attained 262 (141–390) days after MMF treatment, and 151 (117–305) days following IVCYC ( p = 0.17). Time to renal flare was 451 (157–1266) days for MMF, and 343 (198–635) days for IVCYC ( p = 0.47). Conclusion This is the largest study to date investigating induction treatments for proliferative LN in children, demonstrating comparability of MMF and IVCYC.
Collapse
Affiliation(s)
- EMD Smith
- Department of Women and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
- Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - E Al-Abadi
- Department of Rheumatology, Birmingham Children's Hospital, Birmingham, UK
| | - K Armon
- Department of Paediatric Rheumatology, Cambridge University Hospitals, Cambridge, UK
| | - K Bailey
- Department of Paediatric Rheumatology, Oxford University Hospitals, Oxford, UK
| | - C Ciurtin
- Department of Rheumatology, University College London Hospitals NHS Foundation Trust, London, UK
| | - J Davidson
- Department of Paediatric Rheumatology, Royal Hospital for Sick Children, Edinburgh, UK
| | - J Gardner-Medwin
- Department of Paediatric Rheumatology, NHS Greater Glasgow and Clyde (Yorkhill Division), Glasgow, UK
| | - K Haslam
- Department of Paediatrics, Bradford Royal Infirmary, Bradford, UK
| | - D Hawley
- Department of Paediatric Rheumatology, Sheffield Children's Hospital, Sheffield, UK
| | - A Leahy
- Department of Paediatric Rheumatology, Southampton General Hospital, Southampton, UK
| | - V Leone
- Department of Paediatric Rheumatology, Leeds General Infirmary, Leeds, UK
| | - F McErlane
- Department of Paediatric Rheumatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
| | - D Mewar
- Department of Rheumatology, Royal Liverpool University Hospital, Liverpool, UK
| | - G Modgil
- Department of Paediatrics, Musgrove Park Hospital, Taunton, UK
| | - R Moots
- Department of Rheumatology, University Hospital Aintree, Liverpool, UK
| | - C Pilkington
- Department of Paediatric Rheumatology, Great Ormond Street Hospital, London, UK
| | - A Ramanan
- Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, UK
| | - S Rangaraj
- Department of Paediatric Rheumatology, Nottingham University Hospitals, Nottingham, UK
| | - P Riley
- Department of Paediatric Rheumatology, Royal Manchester Children's Hospital, Manchester, UK
| | - A Sridhar
- Department of Paediatrics, Leicester Royal Infirmary, Leicester, UK
| | - N Wilkinson
- Guy's and St Thomas's NHS Foundation Trust, Evelina Children's Hospital, London, UK
| | - M W Beresford
- Department of Women and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
- Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - C M Hedrich
- Department of Women and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
- Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| |
Collapse
|
28
|
Affiliation(s)
| | | | - K. Bailey
- Rydalmere HospitalSydney
- Rydalmere HospitalVictoria RoadRydalmereN.S.W.2116
| |
Collapse
|
29
|
El-Shenawee M, Vohra N, Bowman T, Bailey K. Cancer detection in excised breast tumors using terahertz imaging and spectroscopy. Biomed Spectrosc Imaging 2019; 8:1-9. [PMID: 32566474 PMCID: PMC7304303 DOI: 10.3233/bsi-190187] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
Terahertz imaging and spectroscopy has demonstrated a potential for differentiating tissue types of excised breast cancer tumors. Pulsed terahertz technology provides a broadband frequency range from 0.1 THz to 4 THz for detecting cancerous tissue. Tumor tissue types of interest include cancer typically manifested as infiltrating ductal or lobular carcinomas, fibro-glandular (healthy connective tissues) and fat. In this work, images of breast tumors excised from human and animal models are reviewed. In addition to alternate fresh tissues, breast cancer tissue phantoms are developed to further evaluate terahertz imaging and the potential use of contrast agents. Terahertz results are successfully validated with pathology images, showing strong differentiation between cancerous and healthy tissues for all freshly excised tissues and types. The advantages, challenges and limitations of THz imaging of breast cancer are discussed.
Collapse
Affiliation(s)
- Magda El-Shenawee
- Department of Electrical Engineering, University of Arkansas, Fayetteville, USA
- Corresponding author.
| | - Nagma Vohra
- Department of Electrical Engineering, University of Arkansas, Fayetteville, USA
| | - Tyler Bowman
- Department of Electrical Engineering, University of Arkansas, Fayetteville, USA
| | - Keith Bailey
- Oklahoma Animal Disease Diagnostic Laboratory, Oklahoma State University, Stillwater, Oklahoma, USA
| |
Collapse
|
30
|
Chavez T, Bowman T, Wu J, Bailey K, El-Shenawee M. Assessment of Terahertz Imaging for Excised Breast Cancer Tumors with Image Morphing. J Infrared Millim Terahertz Waves 2018; 39:1283-1302. [PMID: 30984302 PMCID: PMC6457662 DOI: 10.1007/s10762-018-0529-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Accepted: 07/30/2018] [Indexed: 05/25/2023]
Abstract
This paper presents an image morphing algorithm for quantitative evaluation methodology of terahertz (THz) images of excised breast cancer tumors. Most current studies on the assessment of THz imaging rely on qualitative evaluation, and there is no established benchmark or procedure to quantify the THz imaging performance. The proposed morphing algorithm provides a tool to quantitatively align the THz image with the histopathology image. Freshly excised xenograft murine breast cancer tumors are imaged using the pulsed THz imaging and spectroscopy system in the reflection mode. Upon fixing the tumor tissue in formalin and embedding in paraffin, an FFPE tissue block is produced. A thin slice of the block is prepared for the pathology image while another THz reflection image is produced directly from the block. We developed an algorithm of mesh morphing using homography mapping of the histopathology image to adjust the alignment, shape, and resolution to match the external contour of the tissue in the THz image. Unlike conventional image morphing algorithms that rely on internal features of the source and target images, only the external contour of the tissue is used to avoid bias. Unsupervised Bayesian learning algorithm is applied to THz images to classify the tissue regions of cancer, fat, and muscles present in xenograft breast tumors. The results demonstrate that the proposed mesh morphing algorithm can provide more effective and accurate evaluation of THz imaging compared with existing algorithms. The results also showed that while THz images of FFPE tissue are highly in agreement with pathology images, challenges remain in assessing THz imaging of fresh tissue.
Collapse
Affiliation(s)
- Tanny Chavez
- University of Arkansas, Fayetteville, AR 72701 USA,
| | - Tyler Bowman
- University of Arkansas, Fayetteville, AR 72701 USA,
| | - Jingxian Wu
- University of Arkansas, Fayetteville, AR 72701 USA,
| | - Keith Bailey
- Oklahoma Animal Disease Diagnostic Laboratory, Oklahoma State University, Stillwater,OK, 74076 USA,
| | | |
Collapse
|
31
|
Vohra N, Bowman T, Diaz PM, Rajaram N, Bailey K, El-Shenawee M. Pulsed Terahertz Reflection Imaging of tumors in a spontaneous model of breast cancer. Biomed Phys Eng Express 2018; 4. [PMID: 31275612 DOI: 10.1088/2057-1976/aae699] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We report the use of reflection-mode terahertz (THz) imaging in a transgenic mouse model of breast cancer. Unlike tumor xenografts that are grown from established cell lines, these tumors were spontaneously generated in the mammary fat pad of mice, and are a better representation of human breast cancer. THz imaging results from 7 tumors that recapitulate the compartmental complexity of breast cancer are presented here. Imaging was first performed on freshly excised tumors within an hour of excision and then repeated after fixation with formalin and paraffin. These THz images were then compared with histopathology to determine reflection-mode signals from specific regions within tumor. Our results demonstrate that the THz signal was consistently higher in cancerous tissue compared with fat, muscle, and fibrous tissue. Almost all tumors presented in this work demonstrated advanced stages where cancer infiltrated other tissues like fat and fibrous stroma. As the first known THz investigation in a transgenic model, these results hold promise for THz imaging at different stages of breast cancer.
Collapse
Affiliation(s)
- Nagma Vohra
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Tyler Bowman
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Paola M Diaz
- University of Arkansas, Bell Engineering Center, Department of Biomedical Engineering, Fayetteville, Arkansas, United States
| | - Narasimhan Rajaram
- University of Arkansas, Bell Engineering Center, Department of Biomedical Engineering, Fayetteville, Arkansas, United States
| | - Keith Bailey
- Oklahoma State University, Oklahoma Animal Disease Diagnostic Laboratory, Stillwater, Oklahoma, United States
| | - Magda El-Shenawee
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| |
Collapse
|
32
|
Burmaster S, Schaffert J, Bailey K, LoBue C, Rossetti H, Cullum M. A - 03Implications of Sex and Race/Ethnicity on History of Traumatic Brain Injury and Age of Alzheimer’s Disease Onset. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Tunhasiriwet A, Krittanawong C, Tunthong R, Bailey K, Pislaru C, Kane G. P4536Right atrial mechanics predict outcome in patients diagnosed with pre-capillary pulmonary hypertension. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Tunhasiriwet
- Bangkok Heart Hospital, Cardiovascular Medicine, Bangkok, Thailand
| | - C Krittanawong
- Icahn School of Medicine at Mount Sinai, Medicine, New York, United States of America
| | - R Tunthong
- Bangkok Heart Hospital, Cardiovascular Medicine, Bangkok, Thailand
| | - K Bailey
- Mayo Clinic, Center for Clinical and Translational Science, Rochester, United States of America
| | - C Pislaru
- Mayo Clinic, Cardiovascular Diseases, Rochester, United States of America
| | - G Kane
- Mayo Clinic, Cardiovascular Diseases, Rochester, United States of America
| |
Collapse
|
34
|
Bowman T, Chavez T, Khan K, Wu J, Chakraborty A, Rajaram N, Bailey K, El-Shenawee M. Pulsed terahertz imaging of breast cancer in freshly excised murine tumors. J Biomed Opt 2018; 23:1-13. [PMID: 29446263 PMCID: PMC5812433 DOI: 10.1117/1.jbo.23.2.026004] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2017] [Accepted: 01/23/2018] [Indexed: 05/19/2023]
Abstract
This paper investigates terahertz (THz) imaging and classification of freshly excised murine xenograft breast cancer tumors. These tumors are grown via injection of E0771 breast adenocarcinoma cells into the flank of mice maintained on high-fat diet. Within 1 h of excision, the tumor and adjacent tissues are imaged using a pulsed THz system in the reflection mode. The THz images are classified using a statistical Bayesian mixture model with unsupervised and supervised approaches. Correlation with digitized pathology images is conducted using classification images assigned by a modal class decision rule. The corresponding receiver operating characteristic curves are obtained based on the classification results. A total of 13 tumor samples obtained from 9 tumors are investigated. The results show good correlation of THz images with pathology results in all samples of cancer and fat tissues. For tumor samples of cancer, fat, and muscle tissues, THz images show reasonable correlation with pathology where the primary challenge lies in the overlapping dielectric properties of cancer and muscle tissues. The use of a supervised regression approach shows improvement in the classification images although not consistently in all tissue regions. Advancing THz imaging of breast tumors from mice and the development of accurate statistical models will ultimately progress the technique for the assessment of human breast tumor margins.
Collapse
Affiliation(s)
- Tyler Bowman
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Tanny Chavez
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Kamrul Khan
- University of Arkansas, Science and Engineering Building, Department of Mathematical Sciences, Fayetteville, Arkansas, United States
| | - Jingxian Wu
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| | - Avishek Chakraborty
- University of Arkansas, Science and Engineering Building, Department of Mathematical Sciences, Fayetteville, Arkansas, United States
| | - Narasimhan Rajaram
- University of Arkansas, Bell Engineering Center, Department of Biomedical Engineering, Fayetteville, Arkansas, United States
| | - Keith Bailey
- Oklahoma State University, Oklahoma Animal Disease Diagnostic Laboratory, Stillwater, Oklahoma, United States
| | - Magda El-Shenawee
- University of Arkansas, Bell Engineering Center, Department of Electrical Engineering, Fayetteville, Arkansas, United States
| |
Collapse
|
35
|
Sequiera G, Bailey K, Sareen N, Moudgil M, Abu-El Rub E, Sekaran S, Rockman-Greenberg C, Dhingra S. ESTABLISHMENT OF STABLE IN VITRO CARDIAC MODELS OF KEARNS-SAYRE SYNDROME USING INDUCED PLURIPOTENT STEM CELL TECHNOLOGY. Can J Cardiol 2017. [DOI: 10.1016/j.cjca.2017.07.324] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
36
|
Oda A, Messenger K, Carbajal L, Gardner B, Hammer S, Cerreta A, Lewbart G, Posner L, Bailey K. Plasma propofol concentrations and pharmacodynamic effects in koi carp (Cyprinus carpio) following exposure via immersion. Vet Anaesth Analg 2017. [DOI: 10.1016/j.vaa.2017.09.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
37
|
Gentry-Maharaj A, Karpinskyj C, Glazer C, Burnell M, Bailey K, Apostolidou S, Ryan A, Lanceley A, Fraser L, Jacobs I, Hunter MS, Menon U. Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening. Climacteric 2017; 20:240-247. [PMID: 28326899 PMCID: PMC5448394 DOI: 10.1080/13697137.2017.1301919] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Revised: 01/26/2017] [Accepted: 02/19/2017] [Indexed: 12/04/2022]
Abstract
OBJECTIVES The negative publicity about menopausal hormone therapy (MHT) has led to increased use of complementary and alternative medicines (CAM) and non-pharmacological interventions (NPI) for menopausal symptom relief. We report on the prevalence and predictors of CAM/NPI among UK postmenopausal women. METHOD Postmenopausal women aged 50-74 years were invited to participate in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). A total of 202 638 women were recruited and completed a baseline questionnaire. Of these, 136 020 were sent a postal follow-up-questionnaire between September 2006 and May 2009 which included ever-use of CAM/NPI for menopausal symptom relief. Both questionnaires included MHT use. RESULTS A total of 88 430 (65.0%) women returned a completed follow-up-questionnaire; 22 206 (25.1%) reported ever-use of one or more CAM/NPI. Highest use was reported for herbal therapies (43.8%; 9725/22 206), vitamins (42.6%; 9458/22 206), lifestyle approaches (32.1%; 7137/22 206) and phytoestrogens (21.6%; 4802/22 206). Older women reported less ever-use of herbal therapies, vitamins and phytoestrogens. Lifestyle approaches, aromatherapy/reflexology/acupuncture and homeopathy were similar across age groups. Higher education, Black ethnicity, MHT or previous oral contraceptive pill use were associated with higher CAM/NPI use. Women assessed as being less hopeful about their future were less likely to use CAM/NPI. CONCLUSION One in four postmenopausal women reported ever-use of CAM therapies/NPI for menopausal symptom relief, with lower use reported by older women. Higher levels of education and previous MHT use were positive predictors of CAM/NPI use. UKCTOCS Trial registration: ISRCTN22488978.
Collapse
Affiliation(s)
- A. Gentry-Maharaj
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - C. Karpinskyj
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - C. Glazer
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
- Department of Occupational and Environmental Medicine, Bispebjerg - Frederiksberg Hospital, Institute of Public Health, University of CopenhagenCopenhagenDenmark
| | - M. Burnell
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - K. Bailey
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - S. Apostolidou
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - A. Ryan
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - A. Lanceley
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - L. Fraser
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| | - I. Jacobs
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
- UNSW AustraliaSydneyAustralia
- Centre for Women's Health, Institute of Human Development, University of ManchesterManchesterUK
| | - M. S. Hunter
- Department of Psychology, Institute of Psychiatry, Guy’s Campus, King's College LondonLondonUK
| | - U. Menon
- Gynaecological Cancer Research Centre, Department of Women’s Cancer, Institute for Women's Health, University College LondonLondonUK
| |
Collapse
|
38
|
Lythgoe H, Morgan T, Heaf E, Lloyd O, Al-Abadi E, Armon K, Bailey K, Davidson J, Friswell M, Gardner-Medwin J, Haslam K, Ioannou Y, Leahy A, Leone V, Pilkington C, Rangaraj S, Riley P, Tizard EJ, Wilkinson N, Beresford MW. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. Lupus 2017; 26:1285-1290. [PMID: 28361566 DOI: 10.1177/0961203317700484] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objectives The Systemic Lupus International Collaborating Clinics (SLICC) group proposed revised classification criteria for systemic lupus erythematosus (SLICC-2012 criteria). This study aimed to compare these criteria with the well-established American College of Rheumatology classification criteria (ACR-1997 criteria) in a national cohort of juvenile-onset systemic lupus erythematosus (JSLE) patients and evaluate how patients' classification criteria evolved over time. Methods Data from patients in the UK JSLE Cohort Study with a senior clinician diagnosis of probable evolving, or definite JSLE, were analyzed. Patients were assessed using both classification criteria within 1 year of diagnosis and at latest follow up (following a minimum 12-month follow-up period). Results A total of 226 patients were included. The SLICC-2012 was more sensitive than ACR-1997 at diagnosis (92.9% versus 84.1% p < 0.001) and after follow up (100% versus 92.0% p < 0.001). Most patients meeting the SLICC-2012 criteria and not the ACR-1997 met more than one additional criterion on the SLICC-2012. Conclusions The SLICC-2012 was better able to classify patients with JSLE than the ACR-1997 and did so at an earlier stage in their disease course. SLICC-2012 should be considered for classification of JSLE patients in observational studies and clinical trial eligibility.
Collapse
Affiliation(s)
- H Lythgoe
- 1 Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, UK
- 2 NIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - T Morgan
- 1 Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, UK
| | - E Heaf
- 3 Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - O Lloyd
- 3 Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - E Al-Abadi
- 4 Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK
| | - K Armon
- 5 Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - K Bailey
- 6 Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, UK
| | - J Davidson
- 7 Royal Hospital for Sick Children, Edinburgh, UK
| | - M Friswell
- 8 The Great North Children's Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK
| | | | - K Haslam
- 10 Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
| | - Y Ioannou
- 11 Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK
| | - A Leahy
- 12 Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - V Leone
- 13 Leeds Children's Hospital NHS Trust, Leeds, UK
| | - C Pilkington
- 14 Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - S Rangaraj
- 15 Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, UK
| | - P Riley
- 16 Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| | - E J Tizard
- 17 Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, UK
| | - N Wilkinson
- 18 Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, UK
| | - M W Beresford
- 1 Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, UK
- 2 NIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
- 3 Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| |
Collapse
|
39
|
Barger A, Graca R, Bailey K, Messick J, de Lorimier LP, Fan T, Hoffmann W. Use of Alkaline Phosphatase Staining to Differentiate Canine Osteosarcoma from Other Vimentin-positive Tumors. Vet Pathol 2016; 42:161-5. [PMID: 15753469 DOI: 10.1354/vp.42-2-161] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Aspiration of lytic bone lesions is an excellent diagnostic test in the initial evaluation of primary bone neoplasia. However, cytologically, it can be difficult to differentiate osteosarcoma (OSA) from other bone neoplasms, including fibrosarcoma, chondrosarcoma, synovial cell sarcoma, and plasma cell myeloma. The purpose of this study is to determine the sensitivity and specificity of alkaline phosphatase (ALP) staining to differentiate OSA from other tumors that express vimentin by immunocytochemistry or immunohistochemistry. ALP is a hydrolytic enzyme present in multiple tissues including liver, kidney, intestine, placenta, and bone. Hypothetically, neoplasms actively producing bone should be specifically positive for ALP staining. Unstained, cytologic specimens were incubated for 8-10 minutes with nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate toluidine salt-phosphatase substrate. A positive reaction stains the membrane of the cells gray to black. Samples were counterstained with a Romanowsky's stain to determine whether the sample was of representative cellularity. A total of 61 vimentin-positive neoplasms have been evaluated and confirmed histopathologically. Tumors that expressed vimentin and were positive for ALP included 33 OSAs, one multilobular tumor of bone, one amelanotic melanoma, and one chondrosarcoma. Tumors that expressed vimentin and were negative for ALP included chondrosarcomas (three of four), multiple fibrosarcomas, and multiple synovial cell sarcomas. The sensitivity is 100%, and the specificity is 89%. In conclusion, ALP appears to be a highly sensitive and fairly specific marker in the diagnosis of OSA.
Collapse
Affiliation(s)
- A Barger
- Department of Venterinary Pathology, College of Veterinary Medicine, University of Illinois, 288 SAC, 1008 Hazelwood Drive, Urbana, IL, USA.
| | | | | | | | | | | | | |
Collapse
|
40
|
Cook J, Hardie R, Bailey K, Tapper M, Vickers I, Calder D, Harvey K, Lindo JF. Seroprevalence of human toxocariasis, Jamaica. Trop Biomed 2016; 33:88-94. [PMID: 33579145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Seroprevalence of human toxocariasis was studied, based on 1544 samples selected from a total of 3524 submitted to the University of the West Indies in Kingston, Jamaica for diagnosis of dengue during an epidemic in 2010. The prevalence of anti-Toxocara IgG using the CELISA® (Cellabs) ELISA was 21.2% and males (24.4%) were significantly more likely to be exposed than females (17.5%) [χ2 =10.4; p=0.001]. No association was foundbetween exposure to Toxocara and area of residence (rural vs. urban) [χ2 =0.835; p = 0.409]. Prevalence of infection peaked in adolescents (10-19 years-old) and declined thereafter although a rise in prevalence was seen in older age classes. There was a high prevalence of toxocariasis in Jamaica with significant exposure among school age children with no predilection to either sex. The study will inform future work on elucidating the public health and clinical significance of toxocariasis in Jamaica.
Collapse
Affiliation(s)
- J Cook
- Department of Microbiology, University of the West Indies, Mona, Kingston, Jamaica
| | - R Hardie
- Department of Microbiology, University of the West Indies, Mona, Kingston, Jamaica
| | - K Bailey
- Department of Child and Adolescent Health, University of the West Indies, Mona, Kingston, Jamaica
| | - M Tapper
- Department of Microbiology, University of the West Indies, Mona, Kingston, Jamaica
| | - I Vickers
- Department of Microbiology, University of the West Indies, Mona, Kingston, Jamaica
| | - D Calder
- Department of Surgery, Radiology, Anaesthetics and Intensive Care, University of the West Indies, Mona, Kingston, Jamaica
| | - K Harvey
- Ministry of Health, Jamaica, Kingston, Jamaica
| | - J F Lindo
- Department of Microbiology, University of the West Indies, Mona, Kingston, Jamaica
| |
Collapse
|
41
|
Bailey K, Abrams P, Blair PS, Chapple C, Glazener C, Horwood J, Lane JA, McGrath J, Noble S, Pickard R, Taylor G, Young GJ, Drake MJ, Lewis AL. Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial. Trials 2015; 16:567. [PMID: 26651344 PMCID: PMC4676182 DOI: 10.1186/s13063-015-1087-1] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Accepted: 11/26/2015] [Indexed: 11/17/2022] Open
Abstract
Background Lower urinary tract symptoms (LUTS) comprise storage symptoms, voiding symptoms and post-voiding symptoms. Prevalence and severity of LUTS increase with age and the progressive increase in the aged population group has emphasised the importance to our society of appropriate and effective management of male LUTS. Identification of causal mechanisms is needed to optimise treatment and uroflowmetry is the simplest non-invasive test of voiding function. Invasive urodynamics can evaluate storage function and voiding function; however, there is currently insufficient evidence to support urodynamics becoming part of routine practice in the clinical evaluation of male LUTS. Design A 2-arm trial, set in urology departments of at least 26 National Health Service (NHS) hospitals in the United Kingdom (UK), randomising men with bothersome LUTS for whom surgeons would consider offering surgery, between a care pathway based on urodynamic tests with invasive multichannel cystometry and a care pathway based on non-invasive routine tests. The aim of the trial is to determine whether a care pathway not including invasive urodynamics is no worse for men in terms of symptom outcome than one in which it is included, at 18 months after randomisation. This primary clinical outcome will be measured with the International Prostate Symptom Score (IPSS). We will also establish whether inclusion of invasive urodynamics reduces rates of bladder outlet surgery as a main secondary outcome. Discussion The general population has an increased life-expectancy and, as men get older, their prostates enlarge and potentially cause benign prostatic obstruction (BPO) which often requires surgery. Furthermore, voiding symptoms become increasingly prevalent, some of which may not be due to BPO. Therefore, as the population ages, more operations will be considered to relieve BPO, some of which may not actually be appropriate. Hence, there is sustained interest in the diagnostic pathway and this trial could improve the chances of an accurate diagnosis and reduce overall numbers of surgical interventions for BPO in the NHS. The morbidity, and therapy costs, of testing must be weighed against the cost saving of surgery reduction. Trial registration Controlled-trials.com - ISRCTN56164274 (confirmed registration: 8 April 2014). Electronic supplementary material The online version of this article (doi:10.1186/s13063-015-1087-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- K Bailey
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| | - P Abrams
- North Bristol NHS Trust, Bristol Urological Institute, Level 3, Learning and Research Building, Southmead Hospital, Bristol, BS10 5N, UK.
| | - P S Blair
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration, University of Bristol, St. Michael's Hospital, Level D, Southwell Street, Bristol, UK.
| | - C Chapple
- Sheffield Teaching Hospitals NHS Trust, Room H26, H-Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK.
| | - C Glazener
- Health Services Research Unit, University of Aberdeen, 3rd Floor, Health Sciences Building, Foresterhill, Aberdeen, AB25 2ZD, Scotland.
| | - J Horwood
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| | - J A Lane
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| | - J McGrath
- Exeter Surgical Health Services Research Unit - Urology, Royal Devon and Exeter Hospital, Barrack Road, Exeter, Devon, EX2 5DW, UK.
| | - S Noble
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| | - R Pickard
- Institute of Cellular Medicine, University of Newcastle, 3rd Floor, William Leech Building, Newcastle upon Tyne, NE2 4HH, UK.
| | - G Taylor
- University of Plymouth, Plymouth, Devon, PL4 8AA, UK.
| | - G J Young
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| | - M J Drake
- North Bristol NHS Trust, Bristol Urological Institute, Level 3, Learning and Research Building, Southmead Hospital, Bristol, BS10 5N, UK. .,School of Clinical Sciences, University of Bristol, 69 St Michael's Hill, BS2 8DZ, Bristol, UK.
| | - A L Lewis
- School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. .,Bristol Randomised Trials Collaboration (BRTC), University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
| |
Collapse
|
42
|
Kamm J, Bailey K, Kaplan J, McConnell J, Ardolf B, Jaramillo J, Westhafer J, Boyars L, Zartman A. NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS: TRAUMATIC BRAIN INJURYA-23Non-Neuropsychology Providers' Perception of Terminology, Recovery Time, and Treatment Needs in Mild Traumatic Brain Injury. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
43
|
Barker S, White S, Bailey K, Rees P. Acute chest pain in contingency operations at a Role 1 facility. J ROY ARMY MED CORPS 2015; 161:187-91. [PMID: 26265583 DOI: 10.1136/jramc-2015-000497] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2015] [Accepted: 06/27/2015] [Indexed: 11/04/2022]
Abstract
Acute chest pain is a common medical presenting complaint which can be difficult to diagnose and treat outside of a fully equipped emergency department. In future contingency operations the number of personnel deployed is likely be smaller, with the medical cover appropriate for the population at risk, such that the deployed medical facilities will be smaller than the Role 3 unit with which we have become familiar over the last 10 years of operations in Afghanistan. Physician involvement in these smaller medical facilities is crucial to maintain clinical effect when dealing with patients presenting with disease and non-battle injury, which can often make up the majority of deployed healthcare work. Patients presenting with chest pain require rapid assessment and stabilisation prior to medical evacuation to a suitable definitive care unit. This article focuses on emergency acute chest pain presentations, non-cardiac causes of chest pain, risk reduction and how contingency will affect patient care.
Collapse
Affiliation(s)
| | - S White
- Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - K Bailey
- Regional Occupational Health, Queen Elizabeth Memorial Health Centre, Tidworth, UK
| | - P Rees
- Department of Cardiology and Military Medicine, Barts Health NHS Trust & Academic, London, UK
| |
Collapse
|
44
|
Hunter A, Holdsworth DA, D'Arcy J, Bailey K, Casadei B. Hypertension in the military patient. J ROY ARMY MED CORPS 2015; 161:200-5. [PMID: 26253125 DOI: 10.1136/jramc-2015-000506] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2015] [Accepted: 06/29/2015] [Indexed: 11/04/2022]
Abstract
Hypertension and hypertension-related diseases are a leading cause of morbidity and mortality worldwide. A diagnosis of hypertension can have serious occupational implications for military personnel. This article examines the diagnosis and management of hypertension in military personnel, in the context of current international standards. We consider the consequences of hypertension in the military environment and potential military-specific issues relating to hypertension.
Collapse
Affiliation(s)
- Alys Hunter
- MDHU Portsmouth, Queen Alexandra Hospital, Portsmouth, UK
| | - D A Holdsworth
- Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
| | - J D'Arcy
- RCDM (Oxford), John Radcliffe Hospital, Oxford, UK
| | - K Bailey
- AMD, Marlborough Lines, Andover, UK
| | - B Casadei
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
| |
Collapse
|
45
|
Cox AT, D Linton T, Bailey K, Stacey M, Sharma S, Thomas L, Wilson D. An evaluation of the burden placed on the General Internal Medicine team at the Role 3 Hospital in Camp Bastion by UK Armed Forces personnel presenting with symptoms resulting from previously identified disease. J ROY ARMY MED CORPS 2015; 162:18-22. [DOI: 10.1136/jramc-2014-000336] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Accepted: 12/23/2014] [Indexed: 11/04/2022]
|
46
|
Jones MP, Chapman P, Bailey K. The influence of image valence on visual attention and perception of risk in drivers. Accid Anal Prev 2014; 73:296-304. [PMID: 25265192 DOI: 10.1016/j.aap.2014.09.019] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2014] [Revised: 04/04/2014] [Accepted: 09/15/2014] [Indexed: 06/03/2023]
Abstract
Currently there is little research into the relationship between emotion and driving in the context of advertising and distraction. Research that has looked into this also has methodological limitations that could be affecting the results rather than emotional processing (Trick et al., 2012). The current study investigated the relationship between image valence and risk perception, eye movements and physiological reactions. Participants watched hazard perception clips which had emotional images from the international affective picture system overlaid onto them. They rated how hazardous or safe they felt, whilst eye movements, galvanic skin response and heart rate were recorded. Results suggested that participants were more aware of potential hazards when a neutral image had been shown, in comparison to positive and negative valenced images; that is, participants showed higher subjective ratings of risk, larger physiological responses and marginally longer fixation durations when viewing a hazard after a neutral image, but this effect was attenuated after emotional images. It appears that emotional images reduce sensitivity to potential hazards, and we suggest that future studies could apply these findings to higher fidelity paradigms such as driving simulators.
Collapse
Affiliation(s)
- M P Jones
- School of Psychology, University of Nottingham, Nottingham, England, United Kingdom
| | - P Chapman
- School of Psychology, University of Nottingham, Nottingham, England, United Kingdom
| | - K Bailey
- School of Psychology, University of Nottingham, Nottingham, England, United Kingdom
| |
Collapse
|
47
|
Bailey K, Pikhart H, Ryan A, Apostolidou S, Fourkala E, Burnell M, Gentry-Maharaj A, Kalsi J, Parmar M, Jacobs I, Menon U. Socioeconomic inequalities in mortality in national sample of English women: the UKCTOCS Study. Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku151.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
48
|
Del-Aguila JL, Cooper-DeHoff RM, Chapman AB, Gums JG, Beitelshees AL, Bailey K, Turner ST, Johnson JA, Boerwinkle E. Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide. Pharmacogenomics J 2014; 15:153-7. [PMID: 25201287 DOI: 10.1038/tpj.2014.46] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Revised: 06/25/2014] [Accepted: 06/30/2014] [Indexed: 01/22/2023]
Abstract
Hypokalemia is a recognized adverse effect of thiazide diuretic treatment. This phenomenon, which may impair insulin secretion, has been suggested to be a reason for the adverse effects on glucose metabolism associated with thiazide diuretic treatment of hypertension. However, the mechanisms underlying thiazide diuretic-induced hypokalemia are not well understood. In an effort to identify genes or genomic regions associated with potassium response to hydrochlorothiazide, without a priori knowledge of biologic effects, we performed a genome-wide association study and a multiethnic meta-analysis in 718 European- and African-American hypertensive participants from two different pharmacogenetic studies. Single-nucleotide polymorphisms rs10845697 (Bayes factor=5.560) on chromosome 12, near to the HEME binding protein 1 gene, and rs11135740 (Bayes factor=5.258) on chromosome 8, near to the Mitoferrin-1 gene, reached genome-wide association study significance (Bayes factor >5). These results, if replicated, suggest a novel mechanism involving effects of genes in the HEME pathway influencing hydrochlorothiazide-induced renal potassium loss.
Collapse
Affiliation(s)
- J L Del-Aguila
- Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - R M Cooper-DeHoff
- Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA
| | - A B Chapman
- Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
| | - J G Gums
- Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA
| | - A L Beitelshees
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
| | - K Bailey
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
| | - S T Turner
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
| | - J A Johnson
- Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA
| | - E Boerwinkle
- 1] Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, USA [2] Human Genome Sequencing Center at Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
49
|
Subramanian R, Aidasani D, Bailey K, Branstetter D, Everds N, Jiang J, Norman MH, Primack R, Skiles GL, Soto I, Stec MM, Wagner M, Wu T, Zhu X, Lebrec H. P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors. Toxicol Sci 2014; 142:298-310. [DOI: 10.1093/toxsci/kfu178] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Friedman PA, Bradley D, Koestler C, Slusser J, Hodge D, Bailey K, Kusumoto F, Munger TM, Militanu A, Glikson M. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. Europace 2014; 16:1460-8. [DOI: 10.1093/europace/euu022] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
|